azoxymethane has been researched along with Hepatic Encephalopathy in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bobula, B; Orzeł-Gajowik, K; Popek, M; Zielińska, M | 1 |
| Hamano, F; Kihara, Y; Masago, K; Nakagawa, S; Niwa, M; Shimizu, T; Yanagida, K | 1 |
| DeMorrow, S; Frampton, G; Grant, S; Jaeger, V; Kain, J; McMillin, M; Petrescu, AD; Williams, E | 1 |
| Brahmaroutu, A; DeMorrow, S; Frampton, G; Grant, S; Jefferson, B; McMillin, M; Petrescu, AD; Thomas, A; Williams, E | 1 |
| Bélanger, M; Butterworth, RF; Chastre, A; Nguyen, BN | 1 |
| Hazell, AS; Mehta, SL; Silva, VR; Vemuganti, R | 1 |
| Alpini, G; DeMorrow, S; Frampton, G; Galindo, C; McMillin, M; Standeford, H; Thompson, M; Whittington, E | 1 |
| Andry, S; Brown, A; DeMorrow, S; Frampton, G; Grant, S; McMillin, M | 1 |
| Bémeur, C; Butterworth, RF; Desjardins, P | 1 |
| Bémeur, C; Butterworth, RF; Desjardins, P; Vaquero, J | 1 |
| Aspinall, RJ; Barnes, L; Bylund, DJ; Cheresh, DA; Lutu-Fuga, K; Pockros, PJ; Weis, SM | 1 |
| Beauchesne, E; Bélanger, M; Butterworth, RF; Chastre, A; Desjardins, P; Nguyen, BN | 1 |
| Benya, RV; Carroll, RE; Danilkovich, AV; Green, RM; Marrero, JA; Matkowskyj, KA | 1 |
13 other study(ies) available for azoxymethane and Hepatic Encephalopathy
| Article | Year |
|---|---|
The Effect of TGF-β1 Reduced Functionality on the Expression of Selected Synaptic Proteins and Electrophysiological Parameters: Implications of Changes Observed in Acute Hepatic Encephalopathy.
Topics: Animals; Antibodies; Azoxymethane; Blood-Brain Barrier; Brain; Cell Line; Disease Models, Animal; Down-Regulation; Electrophysiological Phenomena; Hepatic Encephalopathy; Injections, Intraperitoneal; Liver Failure, Acute; Male; Mice; Rats; Synaptophysin; Synaptotagmins; Transforming Growth Factor beta1 | 2022 |
Lysophosphatidic acid receptor, LPA
Topics: Animals; Azoxymethane; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cells, Cultured; Endothelial Cells; Hepatic Encephalopathy; Liver Failure, Acute; Lysophospholipids; Male; Mice, Inbred C57BL; Models, Biological; Phosphoric Diester Hydrolases; Rats; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction | 2018 |
Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice.
Topics: Animals; Azoxymethane; Biomarkers; Brain; Disease Models, Animal; Hepatic Encephalopathy; Liver; Male; Mice; Mice, Inbred C57BL; Thioacetamide | 2018 |
Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice.
Topics: Animals; Antibodies; Azoxymethane; Benzamides; Carcinogens; Cell Line, Transformed; Cerebral Cortex; Disease Models, Animal; Hepatic Encephalopathy; Inflammation; Isoquinolines; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Neurons; Phagocytosis; Pyrazoles; Pyridines; Pyrroles; Receptor, Transforming Growth Factor-beta Type II; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation | 2019 |
Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
Topics: Ammonia; Animals; Azoxymethane; Blood-Brain Barrier; Cytokines; Disease Models, Animal; Hepatic Encephalopathy; Inflammation; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Permeability; Transaminases | 2014 |
Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in cerebral cortex of the mouse [corrected].
Topics: Animals; Azoxymethane; Cerebral Cortex; Gene Expression Profiling; Hepatic Encephalopathy; Liver Failure; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; MicroRNAs; Nerve Tissue Proteins; RNA, Messenger; Signal Transduction | 2014 |
Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.
Topics: Animals; Azoxymethane; Benzamides; Body Temperature; Body Weight; Carcinogens; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Glycine; Hepatic Encephalopathy; Liver; Male; Mice; Mice, Inbred C57BL; Microglia; Nervous System Diseases; Quinazolines; Signal Transduction; Time Factors; Up-Regulation | 2014 |
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice.
Topics: Alanine Transaminase; Animals; Azoxymethane; Bilirubin; Calcium-Binding Proteins; Carcinogens; Cerebral Cortex; Chemokine CX3CL1; Cytokines; Disease Models, Animal; Down-Regulation; Encephalitis; Flow Cytometry; Hepatic Encephalopathy; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neuroglia; Phosphopyruvate Hydratase | 2016 |
Antioxidant and anti-inflammatory effects of mild hypothermia in the attenuation of liver injury due to azoxymethane toxicity in the mouse.
Topics: Animals; Antioxidants; Azoxymethane; Brain Edema; Carcinogens; Cytokines; Encephalitis; Free Radical Scavengers; Glutathione; Hepatic Encephalopathy; Hypothermia, Induced; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Transaminases; Treatment Outcome | 2010 |
N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.
Topics: Acetaminophen; Acetylcysteine; Animals; Antioxidants; Azoxymethane; Brain Edema; Carcinogens; Cytokines; Disease Models, Animal; Hepatic Encephalopathy; Inflammation; Inflammation Mediators; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Oxidative Stress | 2010 |
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels.
Topics: Ammonium Chloride; Aniline Compounds; Animals; Apoptosis; Astrocytes; Azoxymethane; Brain; Brain Edema; Cells, Cultured; Disease Models, Animal; Endothelial Growth Factors; Green Fluorescent Proteins; Hepatic Encephalopathy; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-gamma; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Nitriles; Peptides, Cyclic; Protein Kinase Inhibitors; Quinolines; Recombinant Fusion Proteins; src-Family Kinases; Time Factors; Vascular Endothelial Growth Factor A | 2011 |
Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.
Topics: Ammonia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; CD40 Ligand; Cerebrum; Disease Progression; Etanercept; Hepatic Encephalopathy; Immunoglobulin G; Interleukin-6; Liver; Liver Failure, Acute; Male; Mice; Microglia; Oxidative Stress; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2012 |
Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model.
Topics: Animals; Azoxymethane; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Hepatic Encephalopathy; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL | 1999 |